Claudia Rossig Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

1/2022

Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Rossig Research Topics

Disease

64	Neoplasms (Cancer) 04/2024 - 01/2000
14	Ewing Sarcoma (Sarcoma, Ewing) 12/2022 - 06/2013
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2019
10	Neuroblastoma 01/2022 - 11/2008
9	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 01/2014
6	Leukemia 03/2021 - 01/2000
5	Residual Neoplasm 11/2015 - 01/2006
4	Infections 04/2023 - 01/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 05/2015
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2000
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021 - 01/2019
3	Myxoid Liposarcoma 01/2019 - 10/2017
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 10/2017
2	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 01/2021
2	Lymphoma (Lymphomas) 03/2021 - 12/2019
2	Mycoses (Diseases, Fungus) 03/2021 - 01/2018
2	Virus Diseases (Viral Diseases) 03/2015 - 07/2004
2	Bone Marrow Failure Disorders 01/2015 - 07/2010
1	Fever (Fevers) 12/2023
1	Bacterial Infections (Bacterial Infection) 12/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Erythema Infectiosum (Fifth Disease) 04/2023
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Carcinogenesis 06/2022
1	Toxic Optic Neuropathy 01/2022
1	Glioma (Gliomas) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2021

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 04/2024 - 12/2006
24	Chimeric Antigen ReceptorsIBA 04/2024 - 11/2008
8	Surface Antigens (Surface Antigen)IBA 10/2021 - 09/2007
6	CytokinesIBA 04/2024 - 10/2014
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2015
5	Inotuzumab OzogamicinIBA 01/2024 - 01/2019
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 03/2002
4	Transcription Factors (Transcription Factor)IBA 12/2022 - 01/2019
4	AntibodiesIBA 01/2022 - 01/2016
4	blinatumomabIBA 10/2021 - 01/2020
4	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 11/2015
3	Monoclonal AntibodiesIBA 01/2022 - 10/2011
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 08/2013
3	GD2 gangliosideIBA 10/2021 - 01/2018
3	HLA-G Antigens (HLA G)IBA 06/2021 - 01/2017
3	Immune Checkpoint InhibitorsIBA 03/2021 - 12/2019
3	VaccinesIBA 07/2017 - 09/2007
2	Interleukin-18 (Interleukin 18)IBA 04/2024 - 02/2020
2	Protamines (Protamine Sulfate)FDA Link 12/2022 - 01/2022
2	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2022
2	Ifosfamide FDA LinkGeneric 11/2022 - 01/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 06/2021 - 04/2009
2	Gemtuzumab (Mylotarg)FDA Link 03/2021 - 01/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 02/2013
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 10/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 08/2009
2	Antiviral Agents (Antivirals)IBA 04/2019 - 03/2015
2	LigandsIBA 01/2018 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 05/2015
2	Interleukin-2 (IL2)IBA 01/2016 - 05/2015
2	Zoledronic Acid (Zometa)FDA Link 01/2016 - 06/2013
2	Peptides (Polypeptides)IBA 03/2012 - 04/2009
2	EpitopesIBA 03/2012 - 04/2009
2	Viral AntigensIBA 03/2002 - 01/2000
1	ParaffinIBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	Thromboplastin (Tissue Factor)IBA 10/2023
1	NeuropeptidesIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	MethyltransferasesIBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Methotrexate (Mexate)FDA LinkGeneric 11/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	SuspensionsIBA 01/2022
1	cobimetinibIBA 01/2022
1	BI 836858IBA 01/2022
1	TabletsIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Decitabine FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 11/2021
1	Hormones (Hormone)IBA 11/2021
1	ontuxizumabIBA 03/2021
1	Abatacept (Orencia)FDA Link 03/2021
1	Rituximab (Mabthera)FDA Link 03/2021
1	tisagenlecleucelIBA 03/2021
1	pembrolizumabIBA 03/2021
1	BW 250 183IBA 03/2021
1	combotoxIBA 03/2021
1	daratumumabIBA 03/2021
1	inolimomabIBA 03/2021
1	obinutuzumabIBA 03/2021

Therapy/Procedure

34	Therapeutics 12/2022 - 01/2000
16	Immunotherapy 04/2022 - 01/2006
10	Drug Therapy (Chemotherapy) 01/2024 - 01/2006
7	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2015
4	Transplantation 04/2023 - 07/2010
3	Stem Cell Transplantation 04/2019 - 07/2010
2	Cell Transplantation 04/2023 - 01/2021
2	Combined Modality Therapy 02/2016 - 06/2013
1	Molecular Targeted Therapy 06/2022